Firalis S.A. (“Firalis”), a Huningue based developer and provider of biomarker products and bioanalytical... read more
Tue, 10/9/18 - 11:44 am
Tue, 10/9/18 - 10:13 am
Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that it has signed a commercialization plan with Pfizer Inc. The plan is under an existing... read more
Tue, 10/9/18 - 09:44 am
Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C financing... read more
Tue, 10/9/18 - 09:23 am
- So far in September and October of 2018 Altimmune has raised over $60 million
- On 10/6/18 the company presented data that showed that the company's NasoVAX was well-tolerated and... read more
Mon, 10/8/18 - 10:46 am